About Dymind
Dymind is a company based in Shenzhen (China) founded in 2012. It operates as a Direct-to-Consumer (D2C) and Professional Services. Dymind offers products and services including DH-6000 Automated Hematology Analysis Line, CA1200 Automated Coagulation Analyzer, and MF1280 Automated Magnetic Particle Flow Cytometry Analyzer. Dymind operates in a competitive market with competitors including Daxor, Epocal, Hemcheck, Cellmic and Essenlix, among others.
- Headquarter Shenzhen, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Shenzhen Dymind Biotechnology Co., Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Sequoia Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dymind
Dymind offers a comprehensive portfolio of products and services, including DH-6000 Automated Hematology Analysis Line, CA1200 Automated Coagulation Analyzer, and MF1280 Automated Magnetic Particle Flow Cytometry Analyzer.
Automated system for efficient blood analysis processing.
Device for precise coagulation testing and analysis.
Analyzer supporting multiple allergen and immune tests.
People of Dymind
Unlock access to complete
Unlock access to complete
Funding Insights of Dymind
Investors in Dymind
Dymind has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Sequoia Capital and BioVenture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
BioVenture is focused on early and growth-stage healthcare investments.
|
Locked | Locked | Locked |
Investor details for Dymind
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dymind
Investment portfolio details for Dymind
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dymind
Detailed financials for Dymind
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dymind Comparisons
Peer comparison for Dymind
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dymind
Dymind operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daxor, Epocal, Hemcheck, Cellmic and Essenlix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Blood volume analyzers are developed by Daxor for diagnostic applications.
|
|
| Locked | Locked | Locked |
Biochips and solid-state diagnostic devices for blood testing are developed.
|
|
| Locked | Locked | Locked |
Devices for detecting hemolyzed blood samples are provided by Hemcheck.
|
|
| Locked | Locked | Locked |
Rapid test readers are developed for chromatographic and fluorescent assays.
|
|
| Locked | Locked | Locked |
Mobile health self-test platform is provided using nanotechnology and AI.
|
|
| Locked | Locked | Locked |
Develops a hand-held blood test device from a single drop of blood.
|
Detailed competitors of Dymind
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dymind
Complete news archive for Dymind
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dymind
Dymind was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Dymind is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Shigeru Takanaka is the current CEO of Dymind.
Dymind, based in Shenzhen, China, is focused on the development and manufacturing of advanced medical diagnostic equipment. The company specializes in hematology and coagulation analyzers, serving over 130 countries worldwide. Solutions are designed to enhance diagnostic efficiency and accuracy for healthcare institutions. The product portfolio includes automated systems for blood analysis and immune testing, addressing needs in clinical laboratories. Innovation and quality management are prioritized, with certifications like ISO13485 and CE standards. Dymind also collaborates with global partners to tackle challenges in emerging markets.
Dymind's top competitors include Daxor, Pathshodh Healthcare and Cellmic.
Dymind offers DH-6000 Automated Hematology Analysis Line, CA1200 Automated Coagulation Analyzer, and MF1280 Automated Magnetic Particle Flow Cytometry Analyzer.
Dymind has 2 investors. Key investors include Sequoia Capital, and BioVenture.